§ 4-41-102 — Definitions.

As used in this chapter:
(1) "Adulterant" means any poisonous or deleterious substance in a quantity that may be injurious to human health, including:
(1)(a) pesticides;
(1)(b) heavy metals;
(1)(c) solvents;
(1)(d) microbial life;
(1)(e) artificially derived cannabinoids;
(1)(f) toxins; or
(1)(g) foreign matter.
(2) (2)(a) "Artificially derived cannabinoid" means a chemical substance that is created by a chemical reaction that changes the molecular structure of any chemical substances derived from the cannabis plant.
(2)(b) "Artificially derived cannabinoid" does not include:
(2)(b)(i) a naturally occurring chemical substance that is separated from the cannabis plant by a chemical or mechanical extraction process; or
(2)(b)(ii) cannabinoids that are produced by decarboxylation from a naturally occurring cannabinoid acid without the use of a chemical catalyst.
(3) "Cannabidiol" or "CBD" means the cannabinoid identified as CAS# 13956-29-1.
(4) "Cannabidiolic acid" or "CBDA" means the cannabinoid identified as CAS# 1244-58-2.
(5) "Cannabinoid processor license" means a license that the department issues to a person for the purpose of processing a cannabinoid product.
(6) "Cannabinoid product" means a product that:
(6)(a) contains or is represented to contain one or more naturally occurring cannabinoids;
(6)(b) contains less than the cannabinoid product THC level, by dry weight;
(6)(c) contains a combined amount of total THC and any THC analog that does not exceed 10% of the total cannabinoid content;
(6)(d) does not exceed a total of THC and any THC analog that is greater than:
(6)(d)(i) 5 milligrams per serving; and
(6)(d)(ii) 150 milligrams per package; and
(6)(e) unless the product is in an oil based suspension, has a serving size that:
(6)(e)(i) is an integer; and
(6)(e)(ii) is a discrete unit of the cannabinoid product.
(7) "Cannabinoid product class" means a group of cannabinoid products that:
(7)(a) have all ingredients in common; and
(7)(b) are produced by or for the same company.
(8) "Cannabinoid product THC level" means a combined concentration of total THC and any THC analog of less than 0.3% on a dry weight basis if laboratory testing confirms a result within a measurement of uncertainty that includes the combined concentration of 0.3%.
(9) "Cannabis" means the same as that term is defined in Section 26B-4-201.
(10) "Delta-9-tetrahydrocannabinol" or "delta-9-THC" means the cannabinoid identified as CAS# 1972-08-3, the primary psychotropic cannabinoid in cannabis.
(11) "Industrial hemp" means any part of a cannabis plant, whether growing or not, with a concentration of less than 0.3% tetrahydrocannabinol by dry weight.
(12) "Industrial hemp producer registration" means a registration that the department issues to a person for the purpose of processing industrial hemp or an industrial hemp product.
(13) (13)(a) "Industrial hemp product" means a product made by processing industrial hemp plants or industrial hemp parts.
(13)(b) "Industrial hemp product" does not include cannabinoid material or a cannabinoid product.
(14) "Industrial hemp retailer permit" means a permit that the department issues to a retailer who sells any viable industrial hemp seed or cannabinoid product.
(15) "Key participant" means any of the following:
(15)(a) a licensee;
(15)(b) an operation manager;
(15)(c) a site manager; or
(15)(d) an employee who has access to any industrial hemp material with a THC concentration above 0.3%.
(16) "Licensee" means a person possessing a cannabinoid processor license that the department issues under this chapter.
(17) "Newly identified cannabinoid" means a cannabinoid that:
(17)(a) is not expressly identified by chemical name or CAS number in this chapter; and
(17)(b) is identified by the department under Section 4-41-405.
(18) "Non-compliant material" means:
(18)(a) a hemp plant that does not comply with this chapter, including a cannabis plant with a concentration of 0.3% tetrahydrocannabinol or greater by dry weight;
(18)(b) a cannabinoid product, chemical, or compound with a concentration that exceeds the cannabinoid product THC level; and
(18)(c) a cannabinoid product containing any of the following:
(18)(c)(i) delta-9-tetrahydrocannabiphorol (THCP), the cannabinoid identified as CAS# 54763-99-4;
(18)(c)(ii) delta-8-tetrahydrocannabiphorol (THCP), the cannabinoid identified as CAS# 51768-60-6;
(18)(c)(iii) delta-9-tetrahyrdocannabinol (THC) acetate, the cannabinoid identified as CAS# 23132-17-4;
(18)(c)(iv) delta-8-tetrahydrocannabinol (THC) acetate, the cannabinoid identified as CAS# 23050-54-6;
(18)(c)(v) 9(s)-hexahydrocannabinol (HHC), the cannabinoid identified as CAS# 36403-91-5; or
(18)(c)(vi) 9(r)-hexahyrdocannabinol (HHC), the cannabinoid identified as CAS# 36403-90-4.
(19) "Permittee" means a person possessing a permit that the department issues under this chapter.
(20) "Person" means:
(20)(a) an individual, partnership, association, firm, trust, limited liability company, or corporation; and
(20)(b) an agent or employee of an individual, partnership, association, firm, trust, limited liability company, or corporation.
(21) "Retailer permittee" means a person possessing an industrial hemp retailer permit that the department issues under this chapter.
(22) "Tetrahydrocannabinol" or "THC" means a delta-9-tetrahydrocannabinol, the cannabinoid identified as CAS# 1972-08-3.
(23) (23)(a) "THC analog" means a substance that is structurally or pharmacologically substantially similar to, or is represented as being similar to, delta-9-THC.
(23)(b) "THC analog" does not include the following substances or the naturally occurring acid forms of the following substances:
(23)(b)(i) cannabichromene (CBC), the cannabinoid identified as CAS# 20675-51-8;
(23)(b)(ii) cannabicyclol (CBL), the cannabinoid identified as CAS# 21366-63-2;
(23)(b)(iii) cannabidiol (CBD), the cannabinoid identified as CAS# 13956-29-1;
(23)(b)(iv) cannabidivarol (CBDV), the cannabinoid identified as CAS# 24274-48-4;
(23)(b)(v) cannabielsoin (CBE), the cannabinoid identified as CAS# 52025-76-0;
(23)(b)(vi) cannabigerol (CBG), the cannabinoid identified as CAS# 25654-31-3;
(23)(b)(vii) cannabigerovarin (CBGV), the cannabinoid identified as CAS# 55824-11-8;
(23)(b)(viii) cannabinol (CBN), the cannabinoid identified as CAS# 521-35-7;
(23)(b)(ix) cannabivarin (CBV), the cannabinoid identified as CAS# 33745-21-0; or
(23)(b)(x) delta-9-tetrahydrocannabivarin (THCV), the cannabinoid identified as CAS# 31262-37-0.
(24) "Total cannabidiol" or "total CBD" means the combined amounts of cannabidiol and cannabidiolic acid, calculated as "total CBD = CBD + (CBDA x 0.877)".
(25) "Total tetrahydrocannabinol" or "total THC" means the sum of the determined amounts of delta-9-THC, tertrahydrocannabinolic acid, calculated as "total THC = delta-9-THC + (THCA x 0.877)".
(26) "Transportable industrial hemp concentrate" means any amount of a natural cannabinoid in a purified state that:
(26)(a) is the product of any chemical or physical process applied to naturally occurring biomass that concentrates or isolates the cannabinoids contained in the biomass;
(26)(b) is derived from a cannabis plant that, based on sampling that was collected no more than 30 days before the day on which the cannabis plant was harvested, contains a combined concentration of total THC and any THC analog of less than 0.3% on a dry weight basis;
(26)(c) has a THC and THC analog concentration total that is less than 20% when concentrated from the cannabis plant to the purified state; and
(26)(d) is intended to be processed into a cannabinoid product.

Legislative History

Amended by Chapter 114, 2025 General Session